"Academic Incubator" to develop new medicines of value
01 September 2008GlaxoSmithKline (GSK) has signed its first agreement with the University to optimise the early clinical development of new GSK medicines for obesity and addictive disorders.
Articles about 'Trevor Robbins'
© 2025 University of Cambridge